Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000294143 (LOC105377696, novel transcript antisense to GABRA1) is a predicted, non-coding RNA gene located antisense to the GABRA1 locus. It is currently annotated without experimental evidence for protein product or receptor activity, and there is no data associating it with disease, drug interaction, or a biological function. This gene is distinct from GABRA1, which encodes a subunit (alpha-1) of the GABA_A receptor—a well-known ion channel protein and epilepsy therapeutic target[3][1][5]. The antisense transcript itself (ENSG00000294143) is not recognized as a validated molecular target and lacks functional or clinical relevance in the literature or curated bioinformatics resources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to GABRA1 (LOC105377696).